Keyword: Rajiv De Silva

endo

8. Rajiv De Silva

Endo was struggling when CEO Rajiv de Silva departed last September, turning the reins over to current chief Paul Campanelli. But that didn’t stop de Silva from tallying more than $19 million in 2016 pay.
Person offering money

The top 15 highest-paid biopharma executives

Some of the executive pay rankings are predictable, like Johnson & Johnson's CEO, regardless who's in the job. What's not guaranteed is that the chairman of a generics maker in hot water with the U.S. government and American parents—Mylan's Robert Coury—would step off the company’s employee roster and into the nonexecutive chairman’s job and reap a $97 million package with the move.